Send to

Choose Destination
J Community Genet. 2016 Jul;7(3):243-53. doi: 10.1007/s12687-016-0273-5. Epub 2016 Jul 8.

Carrier screening for beta-thalassemia in the Maldives: perceptions of parents of affected children who did not take part in screening and its consequences.

Author information

School of Population Health, University of Western Australia, Perth, Australia.
School of Population Health, University of Western Australia, Perth, Australia.
School of Health and Environmental Studies, Hamdan Bin Mohammed Smart University, Dubai, United Arab Emirates.
School of Nursing, Midwifery and Indigenous Health, Charles Sturt University, Bathurst, Australia.


The Republic of Maldives (Maldives) is an island nation in the Indian Ocean with a population of 344, 023. Studies show that Maldives has one of the world's highest thalassemia carrier rates. It is estimated that 16-18 % of the Maldivians are β-thalassemia carriers, and approximately 28 new β-thal cases are recorded annually. Poor uptake of screening for the condition is one of the main reasons for this high number of new cases. The aim of this study was to explore the reasons for not testing for thalassemia in Maldives before or after marriage. Findings show that participants did not undergo carrier tests because of poor awareness and not fully knowing the devastating consequences of the condition. The outcomes of not testing were distressing for most participants. Religion played a vital role in all the decisions made by the participants before and after the birth of a β-thal child.


Genetic screening; Maldives; Premarital testing; Thalassemia

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center